- Mylan ships cholesterol drug
- Mylan launches generic version of Trilipix
- CVS Caremark study: More education needed on genetic testing in prescribing antiplatelet drugs
- Lupin launches generic fenofibrate
- New cholesterol, obesity guidelines give greater role to statins, call for more research into weight-loss drugs
PITTSBURGH — Mylan has launched a generic drug for treating cholesterol, the company said Friday.
Mylan announced the launch of fenofibrate tablets in the 48 mg and 145 mg strengths. The drug is used to reduce so-called "bad" low-density lipoprotein cholesterol, total cholesterol, triglycerides and apolipoprotein B while increasing "good" high-density lipoprotein cholesterol in adults with primary hyperocholesterolemia or mixed dyslipidemia.
The drug is a generic version of AbbVie's Tricor. Various versions of the drug had sales of about $1.2 billion during the 12-month period that ended in March 2013, according to IMS Health.
Are you a pharmacy technician working in the retail industry? Find our group on Facebook for more stories like this and join the conversation.